Tuesday, May 4, 2021
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), PepsiCo (PEP), and McDonald’s (MCD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Comcast have outperformed the Zacks Cable Television industry in the last one-year period (+56.3% vs. +38.3%). The Zacks analyst believes that Comcast is benefiting from solid high-speed Internet customer wins as reflected by its first-quarter results.
Its strategy to provide high-speed Internet at an affordable price plays a pivotal role in providing connectivity and improving customer experience. Moreover, coronavirus-led increased media consumption, and work-from-home and online-learning waves bode well for Comcast’s Internet business.
However, Comcast persistently suffers from video-subscriber attrition due to cord cutting. Theme park revenues are expected to suffer from lower footfall. Further, weakness in film business is also a headwind.
(You can read the full research report on Comcast here >>>)
PepsiCo’s shares have gained +3.4% over the last three months against the Zacks Soft Drinks Beverages industry’s gain of +4.2%. The Zacks analyst believes that PepsiCo’s robust fourth quarter results was driven by resilience and strength in the global snacks and foods business as well as gains in the beverage category.
The snacks/food business continued to capitalize on the rise in at-home breakfast and lite snacking trends. However, the company witnessed soft margins on international acquisitions and unforeseen weather-related costs in the United States in February. Also, adverse currency rates remain a headwind.
(You can read the full research report on PepsiCo here >>>)
Shares of McDonald’s have gained +8.5% in the past six months against the Zacks Restaurants industry’s gain of +18.9%. The Zacks analyst believes that its increased focus on drive-thru, delivery & take-away is likely to benefit the company.
In order to boost its digital offerings across drive thru, takeaway, delivery, curbside pick-up and dine-in categories, the company is currently working on a new digital experience growth engine “My McDonald’s”. Additionally, the company is making every effort to drive growth in international markets. However, coronavirus related woes continue to remain a concern.
(You can read the full research report on McDonald’s here >>>)
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2022.
Click here for the 4 trades >>
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today’s Must Read
High Speed Internet Subscriber Gain Benefits Comcast (CMCSA)
Momentum in PepsiCo’s (PEP) Snacking Business to Aid Growth
Robust Chipset Business Drives Qualcomm (QCOM) Amid Rivalry
Per the Zacks analyst, Qualcomm is poised to benefit from solid demand for smartphones and the ability to increase the scale of non-handset revenues.
Subscriber Gain Aids Charter (CHTR) Amid Stiff Competition
Per the Zacks analyst, Caterpillar is poised to gain from improving demand in its end markets and focus on strategic investments in expanded offerings, and services, and digital initiatives.
Delivery Business Keeps UBER Afloat Amid Mobility Weakness
The Zacks analyst is optimistic about the surge in UBER’s delivery business. However, despite having improved, the mobility business continues to lag the pre-pandemic levels.
Technology, Loans Aid ICICI Bank (IBN), Credit Quality a Woe
Per the Zacks analyst, ICICI Bank’s efforts to digitize operations, and steady loan and deposit growth will support profitability.
Eni (E) Gains on Refinery Throughputs, Gas Sales Weak
Increasing refinery throughputs across the world, excluding Italy, are aiding the company’s bottom line. However, declining retail gas sales concern the Zacks analyst.
Solid Adoption of ESG Solution Aids MSCI’s (MSCI) Progress
Per the Zacks analyst, MSCI is benefiting from the strong demand for custom and factor index modules and the increasing adoption of the ESG solution into the investment process.
Generac (GNRC) Rides on Solid Revenues & Product Portfolio
Per the Zacks analyst, record revenues and higher shipments on the back of solid demand for both residential and commercial & industrial products drive Generac’s growth momentum.
Rising Loans, Solid Capital Level Aids UMB Financial (UMBF)
Per Zacks analyst, rising loan and deposit balances along with improving net interest and non-interest income are likely to aid UMB Financial’s financials.
Solid DTC E-Commerce Sales Drive Columbia Sportswear (COLM)
Per the Zacks analyst, solid direct-to-consumer e-commerce business has been aiding Columbia Sportswear’s sales, especially amid the pandemic.
Weak Lithium Prices, Lower Volumes Hurt Albemarle (ALB)
Per the Zacks analyst, Albemarle faces a headwind from lower lithium prices due to oversupply in the market. Lower volumes due to weaker fuel demand are also hurting its Catalysts unit.
Antero Midstream (AM) Low Water Volume to Ail Free Cash Flow
The Zacks analyst expects a dent in freshwater delivery volumes due to decreased well-completion activities to reduce Antero Midstream’s free cash flow. Moreover, its debt burden is concerning.
Olorinab Study Failure Hurting Arena’s (ARNA) Prospect
Per the Zacks analyst, failure of Arena’s key candidate olorinab in a mid-stage irritable bowel syndrome study delays pivotal study for the candidate which will lead to delay in commercialization.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
QUALCOMM Incorporated (QCOM): Free Stock Analysis Report
PepsiCo, Inc. (PEP): Free Stock Analysis Report
McDonalds Corporation (MCD): Free Stock Analysis Report
Comcast Corporation (CMCSA): Free Stock Analysis Report
Charter Communications, Inc. (CHTR): Free Stock Analysis Report
Caterpillar Inc. (CAT): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.